Literature DB >> 9620986

Archetype JC virus efficiently replicates in COS-7 cells, simian cells constitutively expressing simian virus 40 T antigen.

K Hara1, C Sugimoto, T Kitamura, N Aoki, F Taguchi, Y Yogo.   

Abstract

JC polyomavirus (JCV), the causative agent of progressive multifocal leukoencephalopathy (PML), is ubiquitous in humans, infecting children asymptomatically and then persisting in the kidney. Renal JCV is not latent but replicates to excrete progeny in the urine. The renal-urinary JCV DNAs carry the archetype regulatory region that generates various rearranged regulatory regions occurring in JCVs derived from the brains of PML patients. Tissue cultures that support the efficient growth of archetype JCV have not been reported. We studied whether archetype JCV could replicate in COS-7 cells, simian cells transformed with an origin-defective mutant of simian virus 40 (SV40). Efficient JCV replication, as detected by a hemagglutination assay, was observed in cultures transfected with five of the six archetype DNAs. The progeny JCVs could be passaged to fresh COS-7 cells. However, when the parental cells of COS-7 not expressing T antigen were transfected with archetype JCV DNAs, no viral replication was detected, indicating that SV40 T antigen is essential for the growth of JCV in COS-7 cells. The archetype regulatory region was conserved during viral growth in COS-7 cells, although a small proportion of JCV DNAs underwent rearrangements outside the regulatory region. We then attempted to recover archetype JCV from urine by viral culture in COS-7 cells. Efficient JCV production was observed in COS-7 cells infected with five of the six JCV-positive urine samples examined. Thus, COS-7 cells should be of use not only for the production of archetype JCV on a large scale but also for the isolation of archetype JCV from urine.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9620986      PMCID: PMC110153     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

Review 1.  Occurrence and significance of papovaviruses BK and JC in the urine.

Authors:  R R Arthur; K V Shah
Journal:  Prog Med Virol       Date:  1989

2.  Genetic characterization of JC virus Tokyo-1 strain, a variant oncogenic in rodents.

Authors:  M Matsuda; M Jona; K Yasui; K Nagashima
Journal:  Virus Res       Date:  1987-04       Impact factor: 3.303

3.  SV40-transformed simian cells support the replication of early SV40 mutants.

Authors:  Y Gluzman
Journal:  Cell       Date:  1981-01       Impact factor: 41.582

4.  Cloned human polyomavirus JC DNA can transform human amnion cells.

Authors:  P M Howley; F Rentier-Delrue; C A Heilman; M F Law; K Chowdhury; M A Israel; K K Takemoto
Journal:  J Virol       Date:  1980-12       Impact factor: 5.103

5.  Characterization of tissue culture-induced heterogeneity in DNAs of independent isolates of JC virus.

Authors:  J D Martin; B L Padgett; D L Walker
Journal:  J Gen Virol       Date:  1983-10       Impact factor: 3.891

6.  Derivation and characterization of POJ cells, transformed human fetal glial cells that retain their permissivity for JC virus.

Authors:  C Mandl; D L Walker; R J Frisque
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

7.  Differences in regulatory sequences of naturally occurring JC virus variants.

Authors:  J D Martin; D M King; J M Slauch; R J Frisque
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

8.  Isolation of a possible archetypal JC virus DNA sequence from nonimmunocompromised individuals.

Authors:  Y Yogo; T Kitamura; C Sugimoto; T Ueki; Y Aso; K Hara; F Taguchi
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

9.  Human polyomavirus JC virus genome.

Authors:  R J Frisque; G L Bream; M T Cannella
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

10.  DNA rearrangements in organ-specific variants of polyomavirus JC strain GS.

Authors:  G Loeber; K Dörries
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

View more
  22 in total

Review 1.  A classification scheme for human polyomavirus JCV variants based on the nucleotide sequence of the noncoding regulatory region.

Authors:  P N Jensen; E O Major
Journal:  J Neurovirol       Date:  2001-08       Impact factor: 2.643

2.  JC virus promoter/enhancers contain TATA box-associated Spi-B-binding sites that support early viral gene expression in primary astrocytes.

Authors:  Leslie J Marshall; Lisa D Moore; Matthew M Mirsky; Eugene O Major
Journal:  J Gen Virol       Date:  2011-11-09       Impact factor: 3.891

3.  Antiviral effects of artesunate on JC polyomavirus replication in COS-7 cells.

Authors:  Biswa Nath Sharma; Manfred Marschall; Christine Hanssen Rinaldo
Journal:  Antimicrob Agents Chemother       Date:  2014-08-25       Impact factor: 5.191

Review 4.  The role of sialic acid in human polyomavirus infections.

Authors:  Gretchen V Gee; Aisling S Dugan; Natia Tsomaia; Dale F Mierke; Walter J Atwood
Journal:  Glycoconj J       Date:  2006-02       Impact factor: 2.916

Review 5.  Role of the environment in the transmission of JC virus.

Authors:  Sílvia Bofill-Mas; Rosina Girones
Journal:  J Neurovirol       Date:  2003       Impact factor: 2.643

6.  Excretion and transmission of JCV in human populations.

Authors:  S Bofill-Mas; R Girones
Journal:  J Neurovirol       Date:  2001-08       Impact factor: 2.643

Review 7.  Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain.

Authors:  Michael W Ferenczy; Leslie J Marshall; Christian D S Nelson; Walter J Atwood; Avindra Nath; Kamel Khalili; Eugene O Major
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

8.  Propagation of archetype and nonarchetype JC virus variants in human fetal brain cultures: demonstration of interference activity by archetype JC virus.

Authors:  Frank J O'Neill; John E Greenlee; Kristina Dörries; Susan A Clawson; Helen Carney
Journal:  J Neurovirol       Date:  2003-10       Impact factor: 2.643

9.  Generation and characterization of JCV permissive hybrid cell lines.

Authors:  Ilker K Sariyer; Mahmut Safak; Jennifer Gordon; Kamel Khalili
Journal:  J Virol Methods       Date:  2009-03-04       Impact factor: 2.014

10.  Pseudovirus mimics cell entry and trafficking of the human polyomavirus JCPyV.

Authors:  Gretchen V Gee; Bethany A O'Hara; Aaron Derdowski; Walter J Atwood
Journal:  Virus Res       Date:  2013-10-04       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.